Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Former FBI Director Robert Mueller has Parkinson’s disease: report

by admin September 1, 2025
September 1, 2025
Former FBI Director Robert Mueller has Parkinson’s disease: report

Former FBI Director Robert Mueller was diagnosed with Parkinson’s disease, his family revealed to the New York Times.

Mueller is the former special counsel who led the Russia investigation into President Donald Trump’s 2016 campaign.

Mueller, 81, was diagnosed in 2021 and retired from public life the following year after briefly teaching law, according to a family statement provided to The Times.

‘Bob was diagnosed with Parkinson’s disease in the summer of 2021. He retired from the practice of law at the end of that year. He taught at his law school alma mater during the fall of both 2021 and 2022, and he retired at the end of 2022,’ the statement said.

This post appeared first on FOX NEWS

previous post
Earthwise Advertising & Investor Awareness Campaign
next post
Trump says he will require voter ID with executive order

Related Posts

Trump pauses aid to Ukraine after fiery meeting...

March 4, 2025

Trump-aligned group sues Chief Justice John Roberts in...

May 6, 2025

Trump’s goodwill tested as Putin ignores peace efforts...

April 26, 2025

EXCLUSIVE: White House rolls out implementation of AI...

April 10, 2025

US pulls team from ceasefire talks in Qatar...

July 25, 2025

Voice of America restored by judge after Trump...

April 23, 2025

JD Vance honors his mother at White House...

April 8, 2025

Trump’s transgender military ban dealt legal blow after...

April 2, 2025

Michelle Obama portraitist’s exhibit with trans Statue of...

July 26, 2025

‘Killed off Elmo’: Jeffries brings along stuffed friend...

June 13, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved